Deputy Director, The George Institute UK
- Associate Professor of Cardiovascular Medicine
- James Martin Senior Fellow in Essential Healthcare at the University of Oxford
- Honorary Consultant Cardiologist at the John Radcliffe Hospital, Oxford
Prof Kazem Rahimi is a cardiologist with research interests in the area of clinical trials and health services research.
As the Deputy Director of The George Institute for Global Health, Kazem leads the Healthcare Innovation and Evaluation programme, which aims to find practical and affordable solutions for the global health priorities of the world¹s largest emerging economies, as well as the priorities of vulnerable or disadvantaged populations in established economies.
Kazem graduated in medicine from the University of Leipzig in Germany with postgraduate training in cardiology, epidemiology, clinical trials and health services research in Leipzig, London and Oxford. Prior to joining the George Institute, in 2010, he was a Research Fellow at Oxford’s Clinical Trial Service and Epidemiological Studies Unit. His research interests include hypertension, heart failure and cardiovascular risk management, using a variety of methodologies such as individual-patient meta-analysis, large-scale complex intervention trials, and digital health technologies.
Kazem is currently the Chief Investigator of several large-scale projects and programmes including the SUPPORT-HF (a trial of remote self-management support in patients with heart failure), UNVEIL-CHF (a programme of research into variation in management of heart failure patients using large clinical datasets), BPLTTC (an international collaboration of blood pressure lowering trialists) and the SUPPORT-CVD trial (a large-scale cluster RCT of risk-stratified prevention and management of CVD with the use of low-cost technologies including the cardiovascular polypill).
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
Conrad NLMS. et al, (2017), Lancet
Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes.
Rahimi K. and Otto CM., (2017), Heart, 103, 1653 - 1655
Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults.
Rahimi K. et al, (2017), PLoS medicine, 14, e1002404 - e1002404
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
Global Burden of Disease 2016 Mortality Collaborators None. and Hay SI., (2017), The Lancet, 390, 1084 - 1084
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Global Burden of Disease 2016 Disease and Injury Incidence and Prevalence Collaborators None. and Hay SI., (2017), The Lancet, 390, 1211 - 1259